Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Organismal metagenomes

ABSTRACT: Biogeography of the respiratory tract microbiome in patients with malignant tracheal tumors

PROVIDER: PRJNA766788 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16232200_1.fastq.gz	Fastqsanger.gz
	SRR16232200_2.fastq.gz	Fastqsanger.gz
	SRR16232300_1.fastq.gz	Fastqsanger.gz
	SRR16232300_2.fastq.gz	Fastqsanger.gz
	SRR16232201_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 380

Similar Datasets

organismal metagenomes

Project description:16S rRNA gene sequencing, comparative analysis of bacterial communities in intestinal tract and respiratory organ of Chinese giant salamander (Andrias davidianus)

| PRJDB5774 | ENA

Transcription profiling of chicken tracheal cells grown in vitro and infected with influenza virus compared to trachea from in vivo infected animals

Project description:Investigation whether tracheal organ cultures (TOCs) are a suitable model for characterization of early immune response triggered by influenza virus infection in the respiratory tract. Comparison to in vivo infected animals.

2009-07-31 | E-MTAB-12 | biostudies-arrayexpress

organismal metagenomes

Project description:Canagliflozin Alters the Gut, Oral, and Ocular Surface Microbiota of Patients with Type 2 diabetes mellitus

| PRJNA978958 | ENA

organismal metagenomes

Project description:Alterations of the Human Oral and Gut Microbiome and Lipid Metabonomics in COVID-19

| PRJNA660302 | ENA

Leveraging the pulmonary immune response and microbiome for improved lower respiratory tract infection diagnosis in critically ill children

Project description:BACKGROUND. Lower respiratory tract infection (LRTI) is a leading cause of death in children worldwide. LRTI diagnosis is challenging since non-infectious respiratory illnesses appear clinically similar and existing microbiologic tests are often falsely negative or detect incidentally-carried microbes common in children. These challenges result in antimicrobial overuse and adverse patient outcomes. Lower airway metagenomics has the potential to detect host and microbial signatures of LRTI. Whether it can be applied at scale and in a pediatric population to enable improved diagnosis and precision treatment remains unclear. METHODS. We used tracheal aspirate RNA-sequencing to profile host gene expression and respiratory microbiota in 261 children with acute respiratory failure. We developed a random forest gene expression classifier for LRTI by training on patients with an established diagnosis of LRTI (n=117) or of non-infectious respiratory failure (n=50). We then developed a classifier that integrates the: i) host LRTI probability, ii) abundance of respiratory viruses, and iii) dominance in the lung microbiome of bacteria/fungi considered pathogenic by a rules-based algorithm. RESULTS. The host classifier achieved a median AUC of 0.967 by 5-fold cross-validation, driven by activation markers of T cells, alveolar macrophages and the interferon response. The integrated classifier achieved a median AUC of 0.986 and significantly increased the confidence of patient classifications. When applied to patients with an uncertain diagnosis (n=94), the integrated classifier indicated LRTI in 52% of cases and nominated likely causal pathogens in 98% of those. CONCLUSIONS. Lower airway metagenomics enables accurate LRTI diagnosis and pathogen identification in a heterogeneous cohort of critically ill children through integration of host, pathogen, and microbiome features.

2022-12-06 | GSE212532 | GEO

Impaired antibacterial immune signaling and changes in the lung microbiome precedes secondary bacterial pneumonia in COVID-19 (scRNA-seq)

Project description:We preformed a systems biological assessment of lower respiratory tract host immune responses and microbiome dynamics in COVD-19 patients, using bulk RNA-sequencing, single-cell RNA sequencing, and techniques, and microbiome analysis. Are focus was on differential gene expression in severe COVID-19 patients who developed ventilator associated pneumonia (VAP) during their course versus severe COVID-19 patients who did not develop VAP. We found early impairment in antibacterial immune signaling in patients two or more weeks prior to the development of VAP, compared to COVID-19 patients who did not develop VAP. There was no signficant difference in viral load, but an association of disruption in lung microbiome by alpha and beta diversity metrics was also found.

2021-03-03 | GSE168018 | GEO

Impaired antibacterial immune signaling and changes in the lung microbiome precedes secondary bacterial pneumonia in COVID-19 (bulkRNA-seq)

2021-03-03 | GSE168017 | GEO

Lower respiratory tract microbiome in criticall illness

Project description:Lower respiratory tract microbiome in critically ill patients

| PRJEB64676 | ENA

Project description:Upper/lower respiratory tract microbiome changes patients with COPD

| PRJNA687932 | ENA

Project description:Microbiome in the respiratory tract of COVID -19 patients

| PRJNA1013128 | ENA